Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Pierdomenico

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Inflammatory Bowel Diseases|January 12, 2016
NOD2 Is Regulated By Mir-320 in Physiological Conditions but this Control Is Altered in Inflamed Tissues of Patients with Inflammatory Bowel DiseaseMaria Pierdomenico, Vincenzo Cesi, Salvatore Cucchiara, et al.
The American Journal of Gastroenterology|July 27, 2011
Fecal HMGB1 is a novel marker of intestinal mucosal inflammation in pediatric inflammatory bowel diseaseRoberta Vitali, Laura Stronati, Anna Negroni, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|June 24, 2016
NOD2 induces autophagy to control AIEC bacteria infectiveness in intestinal epithelial cellsAnna Negroni, Eleonora Colantoni, Roberta Vitali, et al.
Scientific Reports|October 19, 2017
microRNA-181b is increased in cystic fibrosis cells and impairs lipoxin A<sub>4</sub> receptor-dependent mechanisms of inflammation resolution and antimicrobial defenseAnna Maria Pierdomenico, Sara Patruno, Marilina Codagnone, et al.
Journal of Pediatric Gastroenterology and Nutrition|February 22, 2011
New insights into the pathogenesis of inflammatory bowel disease: transcription factors analysis in bioptic tissues from pediatric patientsMaria Pierdomenico, Laura Stronati, Manuela Costanzo, et al.
Frontiers in Immunology|January 9, 2019
Transcription Factor ZNF281: A Novel Player in Intestinal Inflammation and FibrosisMaria Pierdomenico, Franscesca Palone, Vincenzo Cesi, et al.
The American Journal of Gastroenterology|December 11, 2013
Necroptosis is active in children with inflammatory bowel disease and contributes to heighten intestinal inflammationMaria Pierdomenico, Anna Negroni, Laura Stronati, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 11, 2010
Altered expression of innate immunity genes in different intestinal sites of children with ulcerative colitisLaura Stronati, Anna Negroni, Maria Pierdomenico, et al.
Inflammatory Bowel Diseases|July 2, 2014
Role of HMGB1 as a suitable biomarker of subclinical intestinal inflammation and mucosal healing in patients with inflammatory bowel diseaseFrancesca Palone, Roberta Vitali, Salvatore Cucchiara, et al.
Molecular Neurobiology|November 24, 2020
Exposure of the SH-SY5Y Human Neuroblastoma Cells to 50-Hz Magnetic Field: Comparison Between Two-Dimensional (2D) and Three-Dimensional (3D) In Vitro CulturesClaudia Consales, Alessio Butera, Caterina Merla, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Inflammatory Bowel Diseases|January 12, 2016
NOD2 Is Regulated By Mir-320 in Physiological Conditions but this Control Is Altered in Inflamed Tissues of Patients with Inflammatory Bowel DiseaseMaria Pierdomenico, Vincenzo Cesi, Salvatore Cucchiara, et al.
The American Journal of Gastroenterology|July 27, 2011
Fecal HMGB1 is a novel marker of intestinal mucosal inflammation in pediatric inflammatory bowel diseaseRoberta Vitali, Laura Stronati, Anna Negroni, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|June 24, 2016
NOD2 induces autophagy to control AIEC bacteria infectiveness in intestinal epithelial cellsAnna Negroni, Eleonora Colantoni, Roberta Vitali, et al.
Scientific Reports|October 19, 2017
microRNA-181b is increased in cystic fibrosis cells and impairs lipoxin A<sub>4</sub> receptor-dependent mechanisms of inflammation resolution and antimicrobial defenseAnna Maria Pierdomenico, Sara Patruno, Marilina Codagnone, et al.
Journal of Pediatric Gastroenterology and Nutrition|February 22, 2011
New insights into the pathogenesis of inflammatory bowel disease: transcription factors analysis in bioptic tissues from pediatric patientsMaria Pierdomenico, Laura Stronati, Manuela Costanzo, et al.
Frontiers in Immunology|January 9, 2019
Transcription Factor ZNF281: A Novel Player in Intestinal Inflammation and FibrosisMaria Pierdomenico, Franscesca Palone, Vincenzo Cesi, et al.
The American Journal of Gastroenterology|December 11, 2013
Necroptosis is active in children with inflammatory bowel disease and contributes to heighten intestinal inflammationMaria Pierdomenico, Anna Negroni, Laura Stronati, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 11, 2010
Altered expression of innate immunity genes in different intestinal sites of children with ulcerative colitisLaura Stronati, Anna Negroni, Maria Pierdomenico, et al.
Inflammatory Bowel Diseases|July 2, 2014
Role of HMGB1 as a suitable biomarker of subclinical intestinal inflammation and mucosal healing in patients with inflammatory bowel diseaseFrancesca Palone, Roberta Vitali, Salvatore Cucchiara, et al.
Molecular Neurobiology|November 24, 2020
Exposure of the SH-SY5Y Human Neuroblastoma Cells to 50-Hz Magnetic Field: Comparison Between Two-Dimensional (2D) and Three-Dimensional (3D) In Vitro CulturesClaudia Consales, Alessio Butera, Caterina Merla, et al.
Pageof 4